Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 2/20 | 0.56 |
| ▸ | PPARA | Q07869 | 2/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | ACE | P12821 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | IDO1 | P14902 | 2/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20855643 | 0.84 | PPARG (0.45) | PPARGPPARAKMT2ALMNA | |
| SCHEMBL19403466 | 0.84 | PPARG (0.54) | PPARGPPARAMAPTALDH1A1TP53 | |
| SCHEMBL5410393 | 0.83 | GAA (0.61) | GAAMAPTKMT2AACEALDH1A1 | |
| SCHEMBL19385925 | 0.83 | TP53 (0.53) | PPARGPPARAGAAMAPTKMT2A | |
| SCHEMBL19403377 | 0.83 | PPARG (0.55) | PPARGPPARAGAAMAPTKMT2A | |
| SCHEMBL6085105 | 0.83 | GAA (0.53) | PPARGPPARAGAAMAPTKMT2A | |
| SCHEMBL19385923 | 0.82 | PPARG (0.56) | PPARGPPARAGAAMAPTCYP1A2 | |
| SCHEMBL498480 | 0.80 | CYP1A2 (0.67) | PPARGPPARAGAAMAPTKMT2A | |
| SCHEMBL7387748 | 0.80 | HTT (0.56) | GAAKMT2AALDH1A1SMN1; SMN2ATM | |
| SCHEMBL7334996 | 0.80 | GAA (0.57) | GAAMAPTKMT2AACEALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10710061-B2 | Ion pair catalysis of tungstate and molybdate | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2020-07-14 | — | — | US | disclosed |
| US-10710061-B2 | Ion pair catalysis of tungstate and molybdate | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2020-07-14 | — | — | US | disclosed |
| US-20190105646-A1 | ION PAIR CATALYSIS OF TUNGSTATE AND MOLYBDATE | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2019-04-11 | — | — | US | disclosed |
| WO-2017164813-A1 | ION PAIR CATALYSIS OF TUNGSTATE AND MOLYBDATE | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2017-09-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10710061-B2 | Ion pair catalysis of tungstate and molybdate | PRDX3, PRDX4, PRDX2 | PPARG 4299/4885PPARA 3580/4885GAA 3971/4885 |
| US-20190105646-A1 | ION PAIR CATALYSIS OF TUNGSTATE AND MOLYBDATE | PRDX3, PRDX4, PRDX6 | PPARG 4425/4885PPARA 3675/4885GAA 4168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.